Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -14.43M | $ -2.79 | 1 | 5.18M |
3/31/2025 | $ -14.15M | $ -3.98 | 1 | 3.56M |
12/31/2024 | $ -15.84M | $ -17.41 | 1 | 909.8K |
9/30/2024 | $ -16.95M | $ -47 | 1 | 360.67K |
6/30/2024 | $ -16.49M | $ -45.73 | 1 | 360.67K |
3/31/2024 | $ -18.11M | $ -50.2 | 1 | 360.67K |
12/31/2023 | $ -20.41M | $ -57.61 | 1 | 354.27K |
9/30/2023 | $ -21.18M | $ -58.73 | 1 | 360.67K |
6/30/2023 | $ -21.47M | $ -60.74 | 1 | 353.53K |
3/31/2023 | $ -21.59M | $ -63.17 | 1 | 341.8K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for ERNEXA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -2.3M ] / (Shares WA [ 4.89K ] * Share Factor [ 1 ])
(=) OCFPS [ $ -469.45 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.66 |
median | $ 0.9 |
std | $ 3.42 |